Browse Items (19 total)
- Tags: Drug Administration Schedule
Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer.
Tags: 2005, Adult, Aged, Akram T, American Journal of Obstetrics & Gynecology, Antineoplastic Agents, Carboplatin – Administration and Dosage, Combined, Drug Administration Schedule, Drug Toxicity, Endometrial Neoplasms – Drug Therapy, Fanning J, Human, Kaplan-Meier Estimator, Local – Drug Therapy, Maseelall P, Middle Age, Neoplasm Recurrence, Paclitaxel – Administration and Dosage, Retrospective Design, Severity of Illness, Survival
Clinical impact of temporary therapy interruptions on anticoagulation control in patients treated with warfarin.
Tags: 2013, Aged, American journal of therapeutics, Anticoagulants – Administration and Dosage, Anticoagulants – Therapeutic Use, Atrial Fibrillation – Drug Therapy, Blood Coagulation Disorders – Drug Therapy, Boros Melanie L, Coronary Thrombosis – Drug Therapy, Department of Pharmaceutical Sciences, Department of Pharmacy Practice, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Monitoring, Euthanasia, Female, Gallegos Patrick J, Human, International Normalized Ratio, Male, Middle Age, NEOMED College of Pharmacy, Passive, Postoperative Care, Preoperative Care, Prospective Studies, Retrospective Design, Rybarczyk Amy M, Treatment Outcomes, Venous Thromboembolism – Drug Therapy, Warfarin – Administration and Dosage, Warfarin – Therapeutic Use, Zimmerman Jacob P
Early Uncomplicated Appendicitis-Who Can We Treat Nonoperatively?
Tags: 2018, Administration, Adolescence, Adult, Aged, American Surgeon, Ampicillin – Therapeutic Use, Antibiotics – Therapeutic Use, Appendectomy, Appendicitis – Diagnosis, Appendicitis – Drug Therapy, Appendicitis – Surgery, Drug Administration Schedule, Enzyme Inhibitors – Therapeutic Use, Female, HORATTAS ILEANA K, Horattas Mark C, Human, Injections, Intravenous, Male, Middle Age, Oral, Patient Selection, Penicillins – Therapeutic Use, Prospective Studies, Retrospective Design, Severity of Illness Indices, Treatment Outcomes, VASILIOU ELYA M, Young Adult
Discriminative stimulus properties of (+)cathine, an alkaloid of the khat plant.
Tags: *Discrimination (Psychology)/drug effects, 1990, Alkaloids/*pharmacology, Animals, Catha, Domperidone/pharmacology, Drug Administration Schedule, Drug Tolerance, Haloperidol/pharmacology, Inbred Strains, Male, Pehek E A, Pharmacology, biochemistry, and behavior, Phenylpropanolamine/antagonists & inhibitors/*pharmacology, Plant Extracts/analysis, Psychotropic Drugs/*pharmacology, Rats, Schechter M D
Randomized comparison of gastric pH control with intermittent and continuous intravenous infusion of famotidine in ICU patients.
Tags: 1995, Aged, Analysis of Variance, Black L D, Bredle D L, Department of Internal Medicine, Double-Blind Method, Drug Administration Schedule, Famotidine/administration & dosage/*therapeutic use, Female, Fricker R, Heiselman D E, Hulisz D T, Humans, Hydrogen-Ion Concentration, Infusions, Intensive Care Units, Intravenous, Male, Middle Aged, NEOMED College of Medicine, Prospective Studies, Stomach Ulcer/blood/etiology/*prevention & control, Stomach/*drug effects/physiopathology, The American journal of gastroenterology, Treatment Outcome
Time and dose dependency of the suppression of pulmonary metastases of rat mammary cancer by amiloride.
Tags: 1998, Amiloride/*administration & dosage, Animals, Antineoplastic Agents/*administration & dosage, Arvan M, Clinical & experimental metastasis, Dose-Response Relationship, Drug, Drug Administration Schedule, Evans D M, Experimental/*pathology, Female, Guyton D P, Inbred F344, Lung Neoplasms/pathology/*prevention & control/*secondary, Mammary Neoplasms, Neoplasm Transplantation, Plasminogen Activators/antagonists & inhibitors, Rats, Sloan-Stakleff K, Urokinase-Type Plasminogen Activator/antagonists & inhibitors
Solutions to the problem of bacterial resistance.
Tags: *Drug Resistance, *Practice Guidelines as Topic, 2005, Anti-Bacterial Agents/*therapeutic use, Bacterial, Department of Internal Medicine, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Prescriptions/standards, Drug Utilization, File Thomas M Jr, Humans, NEOMED College of Medicine, Professional Practice/*standards, Treatments in respiratory medicine, Unnecessary Procedures
Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia.
Tags: *Levofloxacin, 2004, Administration, Adult, Anti-Bacterial Agents/*administration & dosage/economics, Bacterial/*drug therapy, Community-Acquired Infections/drug therapy, Current medical research and opinion, Department of Internal Medicine, Drug Administration Schedule, Drug Costs, Female, File Thomas M Jr, Humans, Infusions, Intravenous, Khashab Mohammed M, Male, Milkovich Gary, NEOMED College of Medicine, Ofloxacin/*administration & dosage/economics, Oral, Pneumonia, Tennenberg Alan M, Treatment Outcome, Xiang Jim X, Zadeikis Neringa
Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice.
Tags: 2006, 3, 4-Dihydroxyphenylacetic Acid/metabolism, Androgens/administration & dosage, Animals, Dluzen Dean E, Dopamine Agents/*administration & dosage/toxicity, Dopamine/metabolism, Dose-Response Relationship, Drug, Drug Administration Schedule, Estradiol/administration & dosage/*analogs & derivatives/physiology, Estrogen Antagonists/administration & dosage, Female, Liu Bin, Methamphetamine/*administration & dosage/toxicity, Mice, Neostriatum/*drug effects/metabolism, Nerve Degeneration/chemically induced/prevention & control, Neuroendocrinology, Neuroprotective Agents/administration & dosage, Neurotoxins/*administration & dosage, Ovariectomy, Parkinson Disease/physiopathology, Substantia Nigra/*drug effects/metabolism, Tamoxifen/administration & dosage
Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.
Tags: 2007, 80 and over, Adolescent, Adult, Aged, Anti-Bacterial Agents/*administration & dosage/adverse effects/therapeutic use, Bacterial/*drug therapy/microbiology, Community-Acquired Infections/*drug therapy/microbiology, Department of Internal Medicine, Double-Blind Method, Drug Administration Schedule, Female, File Thomas M Jr, Fluoroquinolones/*administration & dosage/adverse effects/therapeutic use, Gemifloxacin, Georgiev Ognian, Humans, Kostov Kosta, Male, Mandell Lionel A, Middle Aged, Naphthyridines/*administration & dosage/adverse effects/therapeutic use, NEOMED College of Medicine, Pneumococcal/drug therapy/microbiology, Pneumonia, Streptococcus pneumoniae/isolation & purification, The Journal of antimicrobial chemotherapy, Tillotson Glenn, Treatment Outcome
Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanate.
Tags: *Treatment Outcome, 2002, 80 and over, Adolescent, Adult, Aged, Amoxicillin-Potassium Clavulanate Combination/administration & dosage/*pharmacokinetics/pharmacology/*therapeutic use, Amoxicillin/adverse effects/therapeutic use, Bacterial, Bacterial/drug therapy/immunology, Bronchitis/drug therapy/microbiology, Combination/adverse effects/*therapeutic use, Department of Internal Medicine, Double-Blind Method, Drug Administration Schedule, Drug Resistance, Drug Therapy, Female, File Thomas M Jr, Follow-Up Studies, Humans, International journal of antimicrobial agents, Jacobs Michael R, Male, Microbial Sensitivity Tests, Middle Aged, Multicenter Studies as Topic, NEOMED College of Medicine, Pneumonia, Poole Michael D, Respiratory Tract Infections/*drug therapy/metabolism/microbiology, Streptococcal Infections/*drug therapy/metabolism/microbiology, Streptococcus pneumoniae/*drug effects, Wynne Brian
Rohypnol ("roofies") control of drug discrimination: effect of coadministered ethanol or flumenazil.
Tags: 1998, Animals, Anti-Anxiety Agents/*pharmacology, Discrimination Learning/*drug effects, Dose-Response Relationship, Drug, Drug Administration Schedule, Ethanol/*pharmacology, Flumazenil/*pharmacology, Flunitrazepam/*pharmacology, GABA Antagonists/*pharmacology, Male, Pharmacology, biochemistry, and behavior, Rats, Schechter M D, Sprague-Dawley
Discrete versus cumulative dosing in dose-response discrimination studies.
Tags: 1997, 4-methylenedioxyamphetamine/*pharmacology, Animals, Chemical, Cocaine/*pharmacology, Discrimination Learning/*drug effects, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Evaluation, European journal of pharmacology, Male, N-Methyl-3, Preclinical, Rats, Schechter M D, Sprague-Dawley, Stimulation
Safe Readministration of Intravenous Thrombolysis in Recurrent Basilar Thrombosis.
Tags: 2018, Aged, Basilar Artery, Basilar Artery – Drug Effects, Basilar Artery – Physiopathology, Basilar Artery/diagnostic imaging/*drug effects/physiopathology, Cerebral Angiography – Methods, Cerebral Angiography/methods, Computed Tomography Angiography, Department of Internal Medicine, Drug Administration Schedule, Fibrinolytic Agents – Administration and Dosage, Fibrinolytic Agents – Adverse Effects, Fibrinolytic Agents/*administration & dosage/adverse effects, Humans, Infusions, Intracranial Thrombosis, Intracranial Thrombosis – Drug Therapy, Intracranial Thrombosis – Physiopathology, Intracranial Thrombosis/diagnostic imaging/*drug therapy/physiopathology, Intravenous, Itrat Ahmed, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, Khan Alina, Magnetic Resonance Imaging, Male, medication safety, NEOMED College of Medicine, Recombinant Proteins – Administration and Dosage, Recombinant Proteins/administration & dosage, Recurrence, recurrent stroke, Repeat Procedures, Retreatment, thrombolysis, Thrombolytic Therapy – Adverse Effects, Thrombolytic Therapy – Methods, Thrombolytic Therapy/adverse effects/*methods, Thrombosis, Time Factors, Tissue Plasminogen Activator – Administration and Dosage, Tissue Plasminogen Activator – Adverse Effects, Tissue Plasminogen Activator/*administration & dosage/adverse effects, Treatment Outcome, Treatment Outcomes
Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer.
Tags: 2005, Adult, Aged, Akram Tahira, American journal of obstetrics and gynecology, Antineoplastic Agents, Antineoplastic Agents/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use, Carboplatin/administration & dosage, Drug Administration Schedule, Endometrial Neoplasms/*drug therapy, Fanning James, Female, Humans, Local/drug therapy, Maseelall Priya, Middle Aged, Neoplasm Recurrence, Paclitaxel/administration & dosage, Phytogenic/administration & dosage, Survival Analysis, Treatment Outcome
Cytometric study of the female Syrian hamster gallbladder epithelium following sex steroid administration.
Tags: 1993, Adamiec-Beyga E, Animals, Cell Count, Cholelithiasis/*chemically induced/pathology, Cricetinae, Cytoplasm/drug effects, Drug Administration Schedule, Epithelial Cells, Epithelium/drug effects, Estrogens/*pharmacology, Female, Gallbladder/cytology/*drug effects, Gilloteaux J, Karkare S, Kelly T R, Mesocricetus, Progesterone/*pharmacology, Tissue & cell
Phase II study of gefitinib in patients with advanced salivary gland cancers.
Tags: 2015, 80 and over, Adenocarcinoma/drug therapy/mortality/pathology, adenoid cystic carcinoma, Adenoid Cystic/*drug therapy/mortality/pathology, Adult, Aged, Antineoplastic Agents/*therapeutic use, Blumenschein George R Jr, Carcinoma, Department of Internal Medicine, Disease-Free Survival, Dose-Response Relationship, Drug, Drug Administration Schedule, El-Naggar Adel K, Female, Gefitinib, Glisson Bonnie S, Gonzalez-Angulo Ana M, Head & neck, Humans, Jakob John A, Kies Merrill S, Kupferman Michael E, Lee J Jack, Liu Diane D, Local/*drug therapy/mortality/pathology, Male, Maximum Tolerated Dose, Middle Aged, NEOMED College of Medicine, Neoplasm Invasiveness/pathology, Neoplasm Recurrence, Neoplasm Staging, non-adenoid cystic carcinoma, Prognosis, Quinazolines/*therapeutic use, Remission Induction, response to therapy, salivary gland cancer, Salivary Gland Neoplasms/*drug therapy/mortality/pathology, Survival Analysis, Treatment Outcome
Effect of a standardized pharyngitis treatment protocol on use of antibiotics in a pediatric emergency department.
Tags: *Emergency Service, *Practice Guidelines as Topic, 2004, Adolescent, Adult, Akron Children's Hospital, Anti-Bacterial Agents/*therapeutic use, Archives of pediatrics & adolescent medicine, Child, Christopher Norman C, Cohort Studies, Department of Emergency Medicine, Department of Pediatrics, Diaz Maria Carmen G, Dose-Response Relationship, Drug, Drug Administration Schedule, Evidence-Based Medicine, Female, Follow-Up Studies, Hospital, Hospitals, Humans, Male, NEOMED College of Medicine, Pediatric, Pharyngitis/*drug therapy/*microbiology, Preschool, Ramundo Maria L, Streptococcal Infections/*drug therapy/microbiology, Symons Nadine, Treatment Outcome